Table 1 Background of patients
Case | Age | Prior recurrence | Patholoy of the latest tumor before enzalutamide | Time to the last recurrence | Existing Tumors at enzalutamide administration | |||
|---|---|---|---|---|---|---|---|---|
Stage | Grade | AR expression | Number | Lagest size | ||||
1 | 69 | None | T1 | G2 | No | 1 Month | 1 Tumor | 6 mm |
2 | 68 | 1 Time | T1 | G3 | No | 1 Month | 1 Tumor | 3 mm |
3 | 67 | 2 Times | Ta with CIS | G3 | No | 4 Months | 1 Tumor | 5 mm |
4 | 66 | None | T1 | G3 | No | 1 Month | 1 Tumor | 3 mm |
5 | 57 | None | Ta | G2 | No | 8 Months | 4 Tumors | 5 mm |
6 | 52 | None | T1 | G3 | No | 1 Month | 1 Tumor | 4 mm |